GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

Date:




The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Transfer Big Board: Best players in each position who could move this summer

Sam TigheJun 15, 2026, 03:00 AM ETCloseSam is a...

What it was like inside Trump birthday event

WASHINGTON — Two presidents walked side by side as...

Britain will restrict social media for kids under age 16

Britain will ban under-16s from using a range of...

Mining Tycoon Gina Rinehart Buys Over $1 Billion SpaceX Stake

Australia’s richest person has bought a more-than $1 billion...